Palatin Technologies Inc. (NYSE AMERICAN: PTN)
$1.81
-0.0200 ( -1.09% ) 70.7K
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
Market Data
Open
$1.81
Previous close
$1.83
Volume
70.7K
Market cap
$29.37M
Day range
$1.79 - $1.87
52 week range
$1.43 - $5.65
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Dec 18, 2023 |
4 | Insider transactions | 1 | Dec 08, 2023 |
4 | Insider transactions | 1 | Dec 06, 2023 |
10-q | Quarterly Reports | 65 | Nov 14, 2023 |
8-k | 8K-related | 15 | Nov 14, 2023 |
8-k | 8K-related | 21 | Oct 24, 2023 |
8-k | 8K-related | 15 | Oct 19, 2023 |
8-k | 8K-related | 15 | Oct 13, 2023 |
8-k | 8K-related | 15 | Sep 28, 2023 |
10-k | Annual reports | 82 | Sep 28, 2023 |